All News

Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 Recent Development, Covid-19 Effect Analysis by Top Companies and Forecast 2027||Astellas Pharma Inc, Fate Therapeutics, Bristol-Myers Squibb Company, ViaCyte, Inc., CELGENE CORPORATION

A reliable Induced Pluripotent Stem Cells advertising report has been set up by ensuring that the vital elements of the healthcare business are seen well to give the market report that has total outline of the market, covering different angles, for example, item definition, market division dependent on different boundaries, and the common vendor landscape. The report gives market definition as market driving variables and market restrictions which helps in assessing the necessity of specific item where a few perspectives must be thought of. The information and data remembered for the huge scope Induced Pluripotent Stem Cells market report enables healthcare industry to take quality choices and plan about the publicizing and deals advancement system all the more effectively.
Induced pluripotent stem cells (iPSCs) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2,442.97 million by 2027 growing at a CAGR of 7.5% in the above-mentioned forecast period.

Some of the key players profiled in the report are FUJIFILM Holdings Corporation, Astellas Pharma Inc, Fate Therapeutics, Bristol-Myers Squibb Company, ViaCyte, Inc., CELGENE CORPORATION, Vericel Corporation, KCI Licensing, Inc, STEMCELL Technologies Inc., Japan Tissue Engineering Co., Ltd., Organogenesis Holdings Inc, Lonza, Takara Bio Inc., Horizon Discovery Group plc, Thermo Fisher Scientific.

Benefits of the report for Induced Pluripotent Stem Cells (iPSCs) market

  1. What are the challenges being faced by the new entrants
  2. Drivers and restrains of the market 
  3. Key developments in the market
  4. Market volume 
  5. CAGR value for the forecast period 2020-2027

Global Induced Pluripotent Stem Cells (iPSCs) Market Scope and Market Size

Induced pluripotent stem cells (iPSCs) market is segmented of the basis of derived cell type, application and end- user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on derived cell type, the induced pluripotent stem cells (iPSCs) market is segmented into hepatocytes, fibroblasts, keratinocytes, amniotic cells, neuronal cells, cardiac cells, vascular cells, immune cells, renal cells, liver cells and others.
  • The application segment of the induced pluripotent stem cells (iPSCs) market is bifurcated into academic research, drug development & discovery, toxicity screening and regenerative medicine.
  • End- user segment of the induced pluripotent stem cells (iPSCs) market is divided into hospitals, biotechnology companies, research laboratories

Now Get 20% Discount on This Report @

Key Developments in the Market:

In March 2018, Kaneka Corporation announced that they have acquired a patent in the Japan for the creation of the method to mass-culture pluripotent stem cells including iPS cells and ES cells. This will help the company to use the technology to produce high quality pluripotent stem cells which can be used in the drug and cell therapy.

In March 2015, Fujifilm announced that they have acquired Cellular Dynamics International. The main aim of the acquisition is to expand their business in the iPS cell-based drug discovery support service with the use of CDS technology. It will help them to product high- quality automatic human cells with the help of the induced pluripotent stem cells. This will help the company to be more competitive in the drug discovery and regenerative medicine.

Global Induced Pluripotent Stem Cells (iPSCs) Market Drivers:

Increasing R&D investment activities is expected to create new opportunity for the market.

Increasing demand for personalized regenerative cell therapies among medical researchers & healthcare is expected to enhance the market growth. Some of the other factors such as increasing cases of chronic diseases, growing awareness among patient, rising funding by government & private sectors and rising number of clinical trials is expected to drive the induced pluripotent stem cells (iPSCs) market in the forecast period of 2020 to 2027.

High cost of the induced pluripotent stem cells (iPSCs) and increasing ethical issues & lengthy processes is expected to hamper the market growth in the mentioned forecast period.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Market Overview
  4. Executive Summary
  5. Premium Insights
  6. By Component
  7. Product Type
  8. Delivery
  9. Industry Type
  10. Geography
    • Overview
    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East & Africa
  11. Company Landscape
  12. Company Profiles
  13. Related Reports

Access Full report @

Analysis based on

  1. What was the market size in 2020?
  2. What are the moves of key players?
  3. Which region is leading the market at global level?
  4. A comprehensive/competitive analysis of the market?
  5. Strategies of key players and product offerings

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]